Apralan 100 Vet Premix 100 mg/g Prémélange médicamenteux
Apralan 100 Vet Premix 100 mg/g Prémélange médicamenteux
Not authorised
- Apramycin sulfate
Product identification
Medicine name:
Apralan 100 Vet Premix 100 mg/g Prémélange médicamenteux
Active substance:
- Apramycin sulfate
Target species:
-
Pig
Route of administration:
-
Oral use
Product details
Active substance and strength:
-
Apramycin sulfate118.20/milligram(s)1.00gram(s)
Pharmaceutical form:
-
Premix for medicated feeding stuff
Withdrawal period by route of administration:
-
Oral use
-
Pig
-
Meat and offal1day
-
-
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QJ01GB90
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Surrendered
Authorised in:
-
Belgium
Package description:
- Apralan 100 Vet Premix 100 mg/g 1 bag (laminate) of 25 kg
- Apralan 100 Vet Premix 100 mg/g 1 bag (laminate) of 5 kg
- Apralan 100 Vet Premix 100 mg/g 1 bag (laminate) of 1 kg
- Apralan 100 Vet Premix 100 mg/g 1 bag (paper/PE) of 25 kg
- Apralan 100 Vet Premix 100 mg/g 1 bag (paper/PE) of 5 kg
- Apralan 100 Vet Premix 100 mg/g 1 bag (paper/PE) of 1 kg
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Full application - known active substance (Article 8 of Regulation (EU) 2019/6)
Marketing authorisation holder:
- Eli Lilly Benelux
Marketing authorisation date:
Manufacturing sites for batch release:
- Eli Lilly Benelux
Responsible authority:
- Federal Agency For Medicines And Health Products
Authorisation number:
This information is not available for this product.
Date of authorisation status change:
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet